Machine Learning Analysis Links Cellular Senescence and Cuproptosis to Sepsis Pathogenesis

A new machine learning-based model has identified 11 key genes that integrate cellular senescence and copper-dependent cell death pathways, offering novel diagnostic biomarkers and therapeutic targets for immune-metabolic dysregulation in sepsis.

Researchers integrated transcriptomic data from three Gene Expression Omnibus datasets (GSE28750, GSE54514, and GSE131761), encompassing 218 sepsis and 89 normal samples, to evaluate the roles of copper-dependent cell death (cuproptosis) and cellular senescence in sepsis.

The analysis identified 17 cuproptosis- and cellular senescence-related differentially expressed genes (CCSRDEGs) between the sepsis and normal groups.

By applying least absolute shrinkage and selection operator (LASSO) regression and random forest machine learning algorithms, researchers identified 11 key diagnostic genes: APP, BACE1, BECN1, CD274, DAXX, DBT, DLAT, DLST, GLS, PDHB, and PRNP.

Among these, BECN1 (beclin 1) exhibited the highest functional similarity to other key genes and played a prominent role in the predictive performance of the sepsis diagnostic model, suggesting that autophagic impairment is a central driver of persistent inflammatory tissue injury in sepsis.

Sepsis is a critical global medical challenge, causing over 11 million deaths annually and representing approximately 20% of all global mortalities.

The clinical utility of current prognostic markers is limited by low specificity and delayed results; identifying precise molecular drivers of the underlying immune-metabolic imbalance is crucial for early intervention.

The study establishes that dysregulated copper levels and mitochondrial dysfunction converge with cellular senescence pathways, fueling metabolic starvation in tissues and driving the inflammatory feedback loops characteristic of the disease.

The model highlights therapeutic targets such as CD274 (PD-L1), which is associated with immune paralysis during sepsis, and PDHB and GLS, which are implicated in mitochondrial pyruvate handling and the 'immunometabolic coupling' of immune cell activation.

This research highlights a growing intersection between acute critical care medicine and therapeutic modalities traditionally associated with chronic aging diseases.

Biotechnology firms focusing on mitochondrial health, autophagy-inducing platforms, or senescence-targeting interventions could leverage these mechanistic links to expand their pipeline indications into acute systemic inflammation and organ failure.

Experimental and laboratory validation of the identified cuproptosis and cellular senescence genes in cell-based and animal models of sepsis to confirm their causal roles.

Prospective clinical evaluation of the 11-gene machine learning diagnostic framework in large, independent patient cohorts to establish its real-world utility and safety as a predictive tool.